Another interesting study is called, "Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B" - Clinical Cancer Research March 2005 11; 2300 by Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon II, Gloria A. Niehans, Robin Vollmer, Dorothy Watson, Mark R. Green, Hedy L. Kindler and on behalf of the Cancer and Leukemia Group B. Here is an excerpt: "Abstract - Purpose: The Cancer and Leukemia Group B conducted a phase II study of
Mesothelioma
No comments:
Post a Comment